• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Get started
Sign in
Advancing epilepsy research: Insights from Truveta’s epilepsy data

Advancing epilepsy research: Insights from Truveta’s epilepsy data

by Truveta Staff | Sep 22, 2023 | Technology

Epilepsy is a complex neurological disorder, characterized by recurrent, unpredictable seizures. The fourth most common neurological disorder in the world, an estimated 3.4 million (3M adults and 470,000 children) have active epilepsy in the US. These seizures...

Recent posts

  • First real-world comparative effectiveness study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
  • Beyond claims data: Truveta showcases potential of EHR data at ISPOR EU 2023
  • Reflections from the inaugural Truveta Symposium


Stay up-to-date

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.